Patents by Inventor Vladimir Tsivinsky

Vladimir Tsivinsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • miRNA-based universal screening test (UST)
    Patent number: 10472681
    Abstract: Described are methods for early noninvasive or minimally invasive detection of pathological changes in organ systems/organs/tissues/cells by quantifying organ system-/organ-/tissue-/cells type-enriched miRNA in bodily fluids.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: November 12, 2019
    Assignee: DIAMIR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman, Vladimir Tsivinsky
  • Methods of using miRNA from bodily fluids for early detection and monitoring of mild cognitive impairment (MCI) and Alzheimer's disease (AD)
    Patent number: 10246747
    Abstract: Described are methods for early diagnosis and progression monitoring of Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) by quantifying neurite and/or synapse miRNAs in bodily fluids.
    Type: Grant
    Filed: December 23, 2016
    Date of Patent: April 2, 2019
    Assignee: DiamiR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman, Vladimir Tsivinsky
  • miRNA-BASED UNIVERSAL SCREENING TEST (UST)
    Publication number: 20170362656
    Abstract: Described are methods for early noninvasive or minimally invasive detection of pathological changes in organ systems/organs/tissues/cells by quantifying organ system-/organ-/tissue-/cells type-enriched miRNA in bodily fluids.
    Type: Application
    Filed: May 26, 2017
    Publication date: December 21, 2017
    Applicant: DIAMIR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman, Vladimir Tsivinsky
  • miRNA-based universal screening test (UST)
    Patent number: 9803242
    Abstract: Described are methods for early noninvasive or minimally invasive detection of pathological changes in organ systems/organs/tissues/cells by quantifying organ system-/organ-/tissue-/cells type-enriched miRNA in bodily fluids.
    Type: Grant
    Filed: April 18, 2012
    Date of Patent: October 31, 2017
    Assignee: DiamiR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman, Vladimir Tsivinsky
  • METHODS OF USING miRNA FROM BODILY FLUIDS FOR EARLY DETECTION AND MONITORING OF MILD COGNITIVE IMPAIRMENT (MCI) AND ALZHEIMER'S DISEASE (AD)
    Publication number: 20170107575
    Abstract: Described are methods for early diagnosis and progression monitoring of Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) by quantifying neurite and/or synapse miRNAs in bodily fluids.
    Type: Application
    Filed: December 23, 2016
    Publication date: April 20, 2017
    Applicant: DiamiR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman, Vladimir Tsivinsky
  • Methods of using miRNA from bodily fluids for early detection and monitoring of mild cognitive impairment (MCI) and alzheimer's disease (AD)
    Patent number: 9556487
    Abstract: Described are methods for early diagnosis and progression monitoring of Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) by quantifying neurite and/or synapse miRNAs in bodily fluids.
    Type: Grant
    Filed: April 18, 2012
    Date of Patent: January 31, 2017
    Assignee: DIAMIR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman, Vladimir Tsivinsky
  • miRNA-BASED UNIVERSAL SCREENING TEST (UST)
    Publication number: 20140256562
    Abstract: Described are methods for early noninvasive or minimally invasive detection of pathological changes in organ systems/organs/tissues/cells by quantifying organ system-/organ-/tissue-/cells type-enriched miRNA in bodily fluids.
    Type: Application
    Filed: April 18, 2012
    Publication date: September 11, 2014
    Applicant: DiamiR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman, Vladimir Tsivinsky
  • METHODS OF USING miRNA FROM BODILY FLUIDS FOR EARLY DETECTION AND MONITORING OF MILD COGNITIVE IMPAIRMENT (MCI) AND ALZHEIMER'S DISEASE (AD)
    Publication number: 20140120545
    Abstract: Described are methods for early diagnosis and progression monitoring of Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) by quantifying neurite and/or synapse miRNAs in bodily fluids.
    Type: Application
    Filed: April 18, 2012
    Publication date: May 1, 2014
    Applicant: DIAMIR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman, Vladimir Tsivinsky